Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
CorMedix Inc.
Bear Case (25th pct.)
78.1% vs price
Base Case (Median)
158.5% vs price
Bull Case (75th pct.)
203.0% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $21.61 | 197.7% | High (40%) |
| Graham Number | $15.92 | 119.3% | Medium (40%) |
| EV/EBITDA | $23.18 | 219.3% | Medium (20%) |
| Earnings Power Value | $3.98 | -45.2% | Medium (50%) |
Based on 4 out of 7 methods, CRMD appears undervalued at the current price of $7.26. The base case fair value of $18.77 implies 158.5% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.